pyrrolidine MCHR1 antagonist 1 [6592]
pyrrolidine MCHR1 antagonist 1
| SMILES |
COc1ccc([C@H]2CN(CCC3(O)CCOCC3)C[C@@H]2CC(=O)Nc2cccc(Cl)c2)cc1 |
| InChIKey |
OLINDOIRFAZHRH-GBXCKJPGSA-N |
Chemical Properties
| Hydrogen bond acceptors |
5 |
| Hydrogen bond donors |
2 |
| Rotatable bonds |
8 |
| Log P |
4.324 |
| Molecular weight (Da) |
472.2 |
| Stereochemistry info |
full |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
pyrrolidine MCHR1 antagonist 1
Drug properties
| Molecular type |
Small molecule |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.